OR WAIT null SECS
Susan Haigney is lead editor of BioPharm International®.
May 23, 2024
The units are being recalled because of incomplete crimp seals and one complaint of a leaking unit.
May 22, 2024
The company is collaborating with the Access to Oncology Medicines Coalition to expand patient access to immuno-oncology therapy Opdivo.
May 20, 2024
The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.
After a review, the agency concluded there was a possible risk of cancer to those exposed to 17-hydroxyprogesterone caproate in the womb.
May 17, 2024
The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.
May 09, 2024
The company’s presentation at ASGCT includes preliminary data results for a child who received the gene therapy.